Logo
x

Search

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (June 13– 17, 2022)

PharmaShots Weekly Snapshots (June 13– 17, 2022)

  • June 17, 2022
Sierra Oncology Reports NDA Submission of Momelotinib to the US FDA for the Treatment of Myelofibrosis

Sierra Oncology Reports NDA Submission of Momelotinib to the US FDA for the Treatment of Myelofibrosis

  • June 17, 2022
Sandoz Reports the EMA Acceptance of Hyrimoz (biosimilar, adalimumab) Application

Sandoz Reports the EMA Acceptance of Hyrimoz (biosimilar, adalimumab) Application

  • June 17, 2022
Basilea and Pfizer Collaborated to Commercialize Cresemba for Invasive Aspergillosis and Mucormycosis

Basilea and Pfizer Collaborated to Commercialize Cresemba for Invasive Aspergillosis and Mucormycosis

  • June 17, 2022
Addex Discontinue P-IIb/III Study of Dipraglurant for the Treatment of Dyskinesia Associated With Parkinson’s Disease

Addex Discontinue P-IIb/III Study of Dipraglurant for the Treatment of Dyskinesia Associated With Parkinson’s Disease

  • June 17, 2022
Henlius Reports the First Patient Dosing in P-III (HLX14-002-PMOP301) Trial of HLX14 (biosimilar, denosumab) to Treat Osteoporosis in Postmenopausal Women

Henlius Reports the First Patient Dosing in P-III (HLX14-002-PMOP301) Trial of HLX14 (biosimilar, denosumab) to Treat Osteoporosis...

  • June 17, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.